[Amikacin in the topical treatment of small losses of substance].
The paper describes the use of aminoglucoside amikacin over 3 years in a group of 187 patients for the topical treatment of skin lesions extending over a maximum 10% of body surface area. The use of amikacin for topical treatment was chosen on the basis of clinical factors; in the majority of cases these were associated to poor circulation in the affected region which created uncertainty as to whether an efficacious dose would be provided by intravenous administration.
Dalla Costa
R
R
Divisione di Chirurgia Plastica e Grandi Ustionati, U.S.L. XIII, Ospedale San Martino, Genova.
Migliori
F
F
Tavilla
P
P
Rizzo
R
R
Cecchi
F
F
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000583:Amikacin / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007871:Leg Ulcer / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D012874:Skin Diseases, Infectious / Q000188:drug therapy*
D000583:Amikacin
L'amikacina nel trattamento topico di piccole perdite di sostanza.